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Regulation of Invasive Cell Behavior by Taiman,
a Drosophila Protein Related to AIB1, a Steroid
Receptor Coactivator Amplified in Breast Cancer
We have been studying a small group of follicle cells
in the Drosophila ovary, the border cells, as a model
system for a forward genetic approach to the study of
cell motility (reviewed in Montell, 1999). The border cells
originate within an epithelium of approximately 1100
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Baltimore, Maryland 21205 follicle cells, which surround a cluster of 16 germline
cells to form an egg chamber (King, 1970). Early in
oogenesis, a pair of specialized follicle cells, called polar
cells, differentiates at each end of the egg chamberSummary
(Ruohola et al., 1991; Margolis and Spradling, 1995;
Tworoger et al., 1999). The anterior polar cells recruitSteroid hormones are key regulators of numerous
an additional four to eight cells, and this cluster thenphysiological and developmental processes, including
detaches from the follicle cell epithelium and invadesmetastasis of breast and ovarian cancer. Here we re-
the neighboring group of fifteen nurse cells.port the identification of a Drosophila gene, named
A number of genes are known to be required to con-taiman, which encodes a steroid hormone receptor
vert the border cells from stationary, epithelial cells tocoactivator related to AIB1. Mutations in tai caused
invasive, migratory cells. The first gene found to be re-defects in the migration of specific follicle cells, the
quired for border cell migration was slow border cellsborder cells, in the Drosophila ovary. Mutant cells ex-
(slbo), which encodes a basic region/leucine zipper tran-hibited abnormal accumulation of E-cadherin, b-cate-
scription factor (Montell et al., 1992) related to the mam-nin, and focal adhesion kinase. TAI protein colocalized
malian CCAAT enhancer binding protein (C/EBP) family.with the ecdysone receptor in vivo and augmented
It has been proposed that expression of C/EBP is onetranscriptional activation by the ecdysone receptor in
factor controlling the timing of border cell migration dur-cultured cells. The finding of this type of coactivator
ing oogenesis.required for cell motility suggests a novel role for ste-
Several genes have been identified whose expressionroid hormones, in stimulating invasive cell behavior,
is regulated, either directly or indirectly, by slbo (re-independent of effects on proliferation.
viewed in Montell, 1999). One of these is breathless (btl),
which encodes a Drosophila FGF receptor homolog thatIntroduction
is known to be required for directional guidance of mi-
grating tracheal cells during embryonic development. ASteroid hormones are key regulators of reproductive
second target for slbo is the gene shotgun (shg), whichbiology and have potent effects on both the develop-
encodes Drosophila E-cadherin (Niewiadomska et al.,ment and physiology of cells of the reproductive organs.
1999), a homophilic cell–cell adhesion molecule. E-cad-In addition, steroid hormones play a key role in the devel-
herin expression is required both in the nurse cells andopment and progression of breast, ovarian, and prostate
in the border cells for normal border cell migration (Odacancers (Schneider and Birkhauser, 1995). In fact, anti-
et al., 1997; Niewiadomska et al., 1999). This finding wasestrogens, such as tamoxifen, are effective therapeutic
somewhat paradoxical since E-cadherin is generally be-agents for these types of cancers (Cuzick, 1996; Green
lieved to promote the formation of stable adherens junc-and Furr, 1999; Jordan, 1999).
tions and epithelial morphology, rather than the transientSteroid hormones exert their effects by binding to
cell–cell adhesions required for cells to migrate (Birch-nuclear receptors, which activate transcription in a li-
meier et al., 1991; Behrens, 1993; Shiozaki et al., 1996;gand-dependent manner. Transcriptional activation also
Guilford, 1999). Nonetheless it is clear that E-cadherin-requires ligand-dependent association with coactivator
mediated cell adhesion is essential to border cell migra-proteins such as AIB1, a steroid receptor coactivator of
tion (Niewiadomska et al., 1999).the p160 class (Leo and Chen, 2000) that is amplified in
In a genetic screen for mutations that cause borderbreast and ovarian cancer (Anzick et al., 1997).
cell migration defects in mosaic clones, we identified aA key feature of cancer progression is increased motil-
number of mutations on chromosome 2R that causeity and invasive behavior of the tumor cells. In addition to
defects in border cell number or position (Liu and Mon-its central role in metastasis, cell motility is a fascinating
tell, 1999). Here we report identification of a novel locus,feature of normal embryonic development. However, the
taiman (tai, pronounced ti-maan’), from a screen for mu-molecular mechanisms that control when and how a
tations on chromosome 2L that caused border cell de-stationary epithelial cell acquires invasive properties are
fects in mosaic clones.not understood in detail. It is clear though that changes
in gene expression, cell adhesion, and cytoskeletal or-
Resultsganization are likely to be important.
tai, a New Locus Required† To whom correspondence should be addressed (e-mail: dmontell@
for Border Cell Migrationjhmi.edu).
We carried out a screen for mutations on the left arm‡ Present address: Department of Cell Biology, Tohoku University
School of Medicine, Sendai 980-8575, Japan. of the second chromosome (2L) that cause border cell
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Figure 1. The tai Mutant Phenotype
(A–C) Nomarski optics images of wild-type
egg chambers stained for b-galactosidase
activity to reveal the expression pattern of
enhancer trap PZ6356, which is expressed
at highest levels in border cells (BCs, open
arrowheads) and the oocyte nucleus (ON,
open arrows). Lower levels of expression can
be seen in other follicle cells and in the nurse
cells (NC) closest to the oocyte (O). The small
arrows indicate the normal extent of migra-
tion of the border cells at the stage shown.
(A) Early stages of oogenesis up to stage 9.
(B) A mid stage 9 egg chamber. The border
cells have migrated partway towards the oo-
cyte. (C) A stage 10 egg chamber. Border cell
migration is complete. (D) A stage 10 slbo
mutant egg chamber. Migration has failed
and b-galactosidase expression from the
PZ6356 enhancer trap is markedly reduced
in the border cells. (E) An egg chamber with
a tai mutant clone. The border cells have
failed to migrate and are located at the ante-
rior tip of the egg chamber. They still express
normal levels of b-galactosidase from the
PZ6356 enhancer trap insertion, which is on
the same chromosome arm as the tai muta-
tion, in this experiment. (F) A second egg chamber with a tai mosaic clone. In this case, partial migration has occurred. (G–I) Fluorescence
micrographs of a border cell cluster. (G) DAPI staining of a border cell cluster undergoing partial migration through the nurse cells. (H) The
same egg chamber as in (G), stained with anti-b galactosidase antibody. In this experiment, b-galactosidase expressing cells are wild type
for tai and b-galactosidase negative cells are mutant for tai (see Experimental Procedures for details). (I) The same egg chamber as in (G)
and (H), stained with an antibody against the SLBO protein. Note that both wild-type and tai mutant border cells (arrows) express SLBO. In
addition, the wild-type cells are located at the front of the cluster and the mutant cells are at the back. This is typical of clusters composed
of a mixture of wild-type and mutant cells. Scale bars 5 50 mm
migration defects in mosaic clones (see Experimental for tai, SLBO protein was expressed similarly in all of
the cells (Figures 1G–1I).Procedures for details). Border cell position was moni-
tored using b-galactosidase expression from an en-
hancer trap line, PZ6356 (Tinker et al., 1998) (Figures Mislocalization of Adhesion Molecules
in tai Mutant Border Cells1A–1F). In wild-type egg chambers, border cells origi-
nate from the anterior follicle cell epithelium (Figure 1A) A second protein that is known to be required for border
cell migration is Drosophila E-cadherin. To determineand migrate during stage 9 in between the nurse cells
(Figure 1B). Migration is complete by stage 10, at which whether the tai migration defect might be due to reduc-
tion in DE-cadherin expression, egg chambers con-point the border cells are invariably found adjacent to the
oocyte nucleus (Figure 1C). In slbo mutants, migration is taining tai mutant clones were stained with antibodies
against DE-cadherin. In all wild-type stages examined,prevented and the border cells are usually located at
the extreme anterior end of the nurse cell cluster (Montell DE-cadherin accumulated in the central, nonmigratory
polar cells, as well as in the junctions between individualet al., 1992, Figure 1D), and PZ6356 expression in the
border cells is significantly reduced (R. Tinker and border cells (Niewiadomska et al., 1999, Figures 2A–2C).
DE-cadherin colocalized with cortical F-actin in thoseD. J. M., unpublished data and Figure 1D).
Of 2885 mutant lines screened for migration defects, locations (Figures 2A9, 2B9, and 2C9). Prior to migration,
when the border cells were still part of the follicularone mutant named taiman61G1 (tai61G1, meaning “too
slow”) was selected for further study. In egg chambers epithelium, DE-cadherin also accumulated at the junc-
tions between border cells and nurse cells (Figures 2Acontaining tai61G1 mosaic clones, PZ6356 expression was
unaffected (Figures 1E and 1F). In some egg chambers and 2A9). However, once the border cells left the fol-
licular epithelium and invaded the neighboring germlinecontaining tai61G1 clones, migration was completely in-
hibited, and border cells remained at the anterior tip of cell cluster, much less DE-cadherin staining was evi-
dent at the junctions between the nurse cells and borderthe egg chamber (Figure 1E). In other egg chambers,
the border cells migrated partway (Figure 1F). Border cells (Figures 2B and 2B9) relative to the level between
border cells or in the polar cells. When migration wascell clusters that underwent partial migration were typi-
cally composed of a mixture of heterozygous and homo- complete, DE-cadherin accumulated again in the junc-
tions between the border cells and the oocyte (Figureszygous mutant cells.
Border cells mutant for tai expressed wild-type levels 2C and 2C9).
In tai mutant clusters, DE-cadherin staining was ab-of the SLBO protein, indicating that the tai mutant phe-
notype was not due to reduced expression of SLBO. normally elevated at the border cell/nurse cell junctions
(Figures 2E and 2E9). In contrast, in slbo mutants, DE-For example, in a border cell cluster composed of a
mixture of wild-type cells and cells homozygous mutant cadherin expression fails to rise at the time of migration
Ecdysone Receptor Coactivator in Cell Motility
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Figure 2. Alterations in DE-Cadherin Accu-
mulation during Border Cell Migration
Fluorescence confocal micrographs of bor-
der cell clusters stained for DE-cadherin
(green) and filamentous actin (red). Colocali-
zation appears yellow. A and A9 show a wild-
type border cell cluster, with central polar
cells (*), in early stage 9, prior to border cell
migration. Note the coaccumulation (yellow)
of DE-cadherin and actin at the junctions be-
tween border cells and nurse cells (NC)
(arrows), in addition to the coaccumulation at
the junctions in between border cells. Actin
is also highly enriched at the junctions in be-
tween nurse cells (NC). B and B9 show a clus-
ter of wild-type border cells amidst the nurse
cells during their migration. Note that there
is still coaccumulation of DE-cadherin and
actin at the junctions between border cells;
however, only punctate expression of DE-
cadherin is apparent at the junctions between
border cells and nurse cells (NC) (arrows). C
and C9 depict border cells after the comple-
tion of migration. DE-cadherin again accumu-
lates to high levels between the border cells
and the neighboring germ cells (arrows). D
and D9 show a cluster of border cells from a
slbo mutant egg chamber. The central polar
cells (*) express normal levels of DE-cadherin;
however, the outer cells only have a basal
level of expression of DE-cadherin. E and E9
show a tai mutant cluster amidst the nurse
cells. Note the accumulation of DE-cadherin
at the junctions between the border cells and
germline cells (arrows), which is as high as
the accumulation at junctions between bor-
der cells. Scale bars 5 15 mm.
(Niewiadomska et al., 1999) and DE-cadherin immunore- DE-cadherin because overexpression of DE-cadherin in
border cells did not cause a migration defect nor specificactivity is only detected at high levels within the polar
cells (Figures 2D and 2D9). Armadillo (ARM) (Peifer and accumulation of cadherin staining at the border cell/
nurse cell junctions (not shown). Nor did the abnormalWieschaus, 1990) colocalized with DE-cadherin in wild-
type and mutant border cells (not shown). The abnormal accumulation of DE-cadherin and ARM appear to be
simply a consequence of the migration failure. In addi-accumulation of DE-cadherin and ARM in tai mutants
did not appear to result from increased transcription of tion to slbo, we have examined DE-cadherin and ARM
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expression in border cells that fail to migrate due to
mutations in the jing locus (Liu and Montell, 2001), and
no defect in either expression or localization of adhesion
complexes was observed. Nor were defects in DE-cad-
herin or ARM expression or localization found in border
cells that fail to migrate due to expression of dominant-
negative Rac (Murphy and Montell, 1996; E. Fields and
D. J. M., unpublished observations).
The accumulation of DE-cadherin at the border cell/
nurse cell boundary suggested that the role of tai in
border cell migration might be to stimulate turnover of
adhesion complexes during migration in order to allow
forward movement. One protein believed to play a role
in turnover of adhesion complexes is FAK (Ilic et al.,
1995). Drosophila FAK (DFAK) (Fox et al., 1999; Fujimoto
et al., 1999; Palmer et al., 1999) is highly enriched in the
border cells during their migration (Fox et al., 1999), but
not in the polar cells (Figures 3A–3D).
To determine whether DFAK expression or localiza-
tion was affected by mutations that disrupt border cell
migration, we stained wild-type and slbo mutant egg
chambers and compared the staining to that of egg
chambers containing tai mosaic clones. DFAK expres-
sion was significantly reduced in slbo mutant border
cells (Figures 3E and 3F). Furthermore, the level of re-
duction correlated with the degree of inhibition of migra-
tion. That is, in some slbo egg chambers, border cell
migration fails completely and the cells remain at the
anterior tip. In such egg chambers, DFAK expression
was undetectable (Figure 3E). In a minority of slbo mu-
tant chambers, the cells migrate a little. In these egg
chambers, DFAK expression was reduced compared to
wild type, but was detectable (Figure 3F). In tai mutant
border cells, DFAK expression was present; however,
its distribution was altered relative to wild type (Figure
3G). Rather than being evenly distributed throughout
the cytoplasm, DFAK appeared to accumulate at the Figure 3. Expression of DFAK in Wild-Type and Mutant Egg
would-be leading edge of the cluster. Some border cell Chambers
clusters that were mutant for tai exhibited partial migra- Confocal micrographs of border cell clusters stained for DFAK
tion and in these clusters, the abnormal distribution of (green) and filamentous actin (red). (A–D) Wild-type. (A) Stage 8 prior
DFAK was only slightly affected such that little DFAK to border cell migration. DFAK accumulates in a few anterior follicle
cells (arrows). (B) Early stage 9, as the border cells initiate migration.accumulation could be detected at the most posterior
(C) Mid stage 9 during migration. (D) Stage 10 when migration isposition within the cluster (Figure 3H). Thus, the severity
complete. Note the specific accumulation of DFAK in the borderof the migration defect in tai mutants correlated with
cells, but not in the central polar cells (*), and the distribution of
the severity of the defect in DFAK localization. DFAK in the border cells is throughout the entire cytoplasm. (E and
F) Stage 10 egg chambers of slbo1310/slbo1310. Border cells, identified
by anti-b-galactosidase staining (purple), remain at the tip of theMolecular Characterization of the tai Locus
egg chambers and expressed no detectable DFAK (E), or little DFAKEight P element alleles of tai were identified (see Experi-
(F). (G and H) Stage 10 egg chambers in which all border cells weremental Procedures), and their insertion points, which
homozygous mutant for tai. Border cells accumulated normal levels
spanned more than 60 kb, are shown in Figure 4A. The but an altered distribution of DFAK. DFAK appeared to accumulate
protein sequence predicted from cDNA analysis and RT- abnormally at the leading edge of the border cell cluster (arrow
PCR is shown in Figure 4B. heads). Scale bar: 10 mm.
The tai locus encoded a protein with amino acid se-
quence similarity to steroid hormone receptor coactiva-
tor proteins of the p160 family (SRCs). SRCs bind to et al., 1998), and one or more polyglutamine stretches
that mediate transcriptional activation. The predictedsteroid hormone receptor (SHR) complexes in a ligand-
dependent manner and potentiate hormone-induced TAI protein contained all of the domains featured in the
p160 class of SRCs (Figures 4B and 4C), and the toptranscriptional activation (Leo and Chen, 2000). The
most related protein was AIB1, a steroid hormone recep- 19 BLAST scores were from members of this family. The
highest level of amino acid sequence identity was foundtor coactivator that is amplified in breast and ovarian
cancer (Anzick et al., 1997). SRCs typically contain a in the bHLH domain, which was 48% identical and 71%
similar between AIB1 and TAI.basic helix-loop-helix (bHLH) domain near the N termi-
nus, a PAS domain, LXXLL motifs, which are responsible The entire coding sequence was cloned into a P ele-
ment transformation vector and expressed in transgenicfor binding to the hormone bound receptor (McInerney
Ecdysone Receptor Coactivator in Cell Motility
1051
Figure 4. Genomic Organization, Sequence, Homology, and Domain Organization of TAI
(A) The splicing pattern of the major TAI RT-PCR product is indicated, as are the sites of insertion of the eight tai P element alleles. The
predicted coding sequence is shaded. (B) Deduced amino acid sequence of the major TAI RT-PCR product. The bHLH domain is shown in
italics and underlined. The PAS domain is underlined. The LXXLL motifs are shown in bold and underlined. The GenBank accession number
for this sequence is AY008258. (C) Schematic diagram of the TAI protein domains compared to AIB1. The percent amino acid identity within
the bHLH domain is shown for the human coactivator AIB1, which is also known as SRC3, TRAM-1, RAC3, and ACTR (see for example Suen
et al., 1998). (D) Rescue of border cell migration defects in egg chambers expressing the TAI transgene under the control of a border cell
enhancer (see Experimental Procedures for details). In this experiment, GFP is expressed only in homozygous mutant cells. In the absence
of the transgene, migration was delayed or prevented. In the presence of the transgene, migration was normal.
flies (see Experimental Procedures for details). We em- was detected in the nurse cells. Widespread expression
was also detected in embryos (not shown). The nucleiployed a system for generating mosaic clones, known
as MARCM, in which only homozygous mutant cells of tai homozygous mutant cells did not react with the
antibody against TAI (Figures 5D† and 5E† ), though theexpress GFP and are therefore easy to identify unambig-
uously (Lee and Luo, 1999). In the presence of the trans- nuclei were present, as detected by DAPI staining (Fig-
ures 5D and 5E). TAI expression was unchanged in slbogene, but not in its absence, migration was rescued in
all tai mutant clusters examined (n . 15) (Figure 4D). mutant egg chambers (Figures 5C and 5C9), indicating
that tai is not a downstream target of slbo.We raised antibodies against two different regions of
the predicted protein, the PASB domain and the LXXLL
domain (see Experimental Procedures). Both antibodies Coexpression and Function of TAI
and the Ecdysone Receptorstained follicle cells in the Drosophila ovary (Figure 5).
Nuclear staining was observed in all of the follicle cells, The similarity of TAI to steroid hormone receptor coacti-
vators suggested that TAI might interact with one orincluding the border cells; however, much less protein
Cell
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Figure 5. Expression of TAI Protein in Drosophila Egg Chambers
(A, B, D, and E) DAPI staining reveals the large nurse cell nuclei as well as the smaller follicle cell nuclei. (A9, B9, C9, D† , and E† ) Anti-TAI
antibody staining. Follicle cells are brightly stained whereas nurse cells are less brightly stained. (A and A9) Wild-type egg chambers stained
for DAPI and TAI showing nuclear localization of TAI protein in all follicle cells including border cells (open arrowheads in A9). (B and B9)
Higher magnification of a stage 10 egg chamber focused on the surface to show that nurse cell associated follicle cells (short arrows) and
columnar follicle cells (long arrows) are also stained. The border cells are out of the plane of focus. (C) A stage 10 slbo mutant egg chamber
stained with anti-b-galactosidase antibody to reveal border cell (open arrowheads) and centripetal follicle cell nuclei. (C9) The same egg
chamber as in (C) stained with anti-TAI antibody to show that slbo mutant border cells express normal levels of TAI (open arrowheads). (D)
DAPI staining of a cluster of tai mutant border cells that has failed to migrate (circle). (D9) Absence of b-galactosidase staining of the same
egg chamber indicates that the border cell cluster is homozygous mutant for tai. (D† ) Absence of staining of the same cluster with anti-TAI
antibodies demonstrates autonomy of the migration defect. (E) DAPI staining of an egg chamber containing tai mosaic clones to visualize all
nuclei. (E9) Anti-b-galactosidase staining of the same egg chamber. Absence of staining indicates cells that are homozygous mutant for tai.
(E† ) Absence of TAI staining colocalizes with absence of b-gal. Scale bars 5 50 mm.
more steroid hormone receptors. The only known ste- EcR-B are distinct isoforms of the EcR subunit, which
are generated by alternative splicing (Talbot et al., 1993).roid hormone in Drosophila is ecdysone, and the ovary
is a major site of ecdysone synthesis, which peaks at USP, EcR-A, and EcR-B colocalized with TAI protein in
migrating border cells (Figure 6). While USP and EcR-Astage 9 (Riddiford, 1993). The functional ecdysone re-
ceptor is a heterodimer composed of Ultraspiracle were expressed generally, in both follicle cells and nurse
cells (Figures 6A9 and 6C9), EcR-B (Figure 6B9) and TAI(USP), which is the fly retinoid X receptor (RXR) homolog,
and EcR (Yao et al., 1993). To determine whether the (Figures 6A† , 6B† , and 6C † ) were specifically enriched
in border cells during the period of their migration.ecdysone receptor complex would be a good candidate
for interaction with TAI, we examined expression of ec- These observations raised the possibility that the tim-
ing of border cell migration might be controlled by ecdy-dysone receptor subunits in egg chambers using anti-
bodies against USP, EcR-A, and EcR-B. EcR-A and sone. To test whether border cell migration was respon-
Ecdysone Receptor Coactivator in Cell Motility
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Figure 6. Colocalization of TAI, USP, and
EcR in Border Cells and Inhibition of Border
Cell Migration by usp Mutation
Immunofluorescence micrographs of egg
chambers stained with DAPI (A–D and D9),
with antibodies against ecdysone receptor
subunits (A9–C9, and D† ), and with anti-TAI
antibodies (A† –C† ). (A)–(C† ) show wild-type
egg chambers while (D), (D9), and (D† ) show an
egg chamber containing usp mosaic clones.
EcR-A is expressed in all cells of the egg
chamber including border cells (A9, open ar-
rowheads). Anti-EcR-B antibody staining is
specifically enriched in border cells (B9), as
is TAI (A† , B† , and C† ). The USP protein (C9)
is expressed in all of the cells but appears to
be expressed at highest levels in border cells
and the nurse cells that are closest to the
oocyte. A stage 10 egg chamber with homo-
zygous usp mutant border cells is shown
stained with DAPI in (D) and (D9). Mutant bor-
der cells are at the anterior tip (open arrow-
heads), whereas normally they should have
arrived at the border between the nurse cells
and oocyte (arrows in [D]). (D9) A high magnifi-
cation view of the DAPI stained border cell clus-
ter shown in (D). (D† ) The same egg chamber
shown in (D) and (D9) stained with antibodies
against the USP protein. Two cells in the clus-
ter that lack USP protein (arrowheads). Two
cells in the middle of the cluster, most likely
the nonmigratory polar cells, still express
USP (long arrows). Scale bars 5 25 mm.
sive to hormone, we analyzed the effects of injecting SLBO protein. Greater than 50% of these egg chambers
exhibited delayed border cell migration (not shown).hormone into female flies. We did not expect that in-
creasing the hormone concentration alone would be Since the effects on border cell migration of increasing
or decreasing ecdysone levels could have been indirect,sufficient to cause precocious border cell migration be-
cause expression of the slbo gene and its targets are we tested whether there was a cell autonomous require-
ment for the ecdysone receptor in border cells. Theindependently required for migration. Therefore, we first
expressed slbo precociously using transgenic flies car- EcR locus is proximal to available FRT insertion sites,
preventing mosaic analysis. Therefore, we carried outrying a heat-inducible slbo transgene, followed by injec-
tion of hormone. Border cell migration was assayed in the analysis using mutations in usp. Border cells that
were homozygous mutant for a null allele of usp exhib-stage 8 egg chambers dissected from flies treated with
heat shock and hormone, and compared to control flies ited inhibition of border cell migration, but no obvious
defects in other follicle cells (Figures 6D, 6D9, and 6D† ).treated with heat shock and ethanol, or with hormone
in the absence of heat shock (see Experimental Proce- To assess whether TAI and the ecdysone receptor
were likely to associate in a complex in vivo, TAI expres-dures for details). Precocious border cell migration was
observed in 20% of egg chambers that were treated sion was examined in third instar larvae. Both antibodies
against TAI reacted specifically with the salivary glandwith both heat shock and hormone but not in controls
(data not shown). The observed effects were consistent nuclei (Figure 7A), as well as other larval tissues (not
shown). Polytene chromosome spreads were stainedwith a role for ecdysone in regulating the timing of border
cell migration. with antibodies against TAI and USP proteins in a double
labeling experiment. As shown in Figure 7D, anti-TAIIf the rising ecdysone level at stage 9 were required
to stimulate border cell migration, then reducing the antibody labeled specific loci on the polytene chromo-
somes. Moreover, USP and TAI proteins colocalized pre-ecdysone level should cause a delay in border cell mi-
gration. The ecdysoneless mutant ecd1 is temperature cisely (Figure 7). Since previous experiments have
shown that USP and EcR colocalize as a complex onsensitive for production of ecdysone. Females homozy-
gous for ecd1 are sterile when held at the nonpermissive polytene chromosomes (Yao et al., 1993), these results
indicated that TAI colocalized with the functional ecdy-temperature for 5 days, and egg chambers in these
flies arrest development at stage 8 and subsequently sone receptor complex at specific target sites.
We also determined whether expression of TAI coulddegenerate. We found that border cells failed to develop
in these arrested egg chambers (not shown). However, enhance ecdysone receptor dependent transcriptional
activation in EcR-293 mammalian cells (see Experimen-when ecd1 mutants were held at the nonpermissive tem-
perature for 2 days, some stage 10 egg chambers devel- tal Procedures for details). These cells respond to hor-
mone, either ecdysone or an analog known as ponaster-oped, in which border cells differentiated and expressed
Cell
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Figure 7. In Vivo and In Vitro Interactions be-
tween TAI, EcR, and USP
(A) Staining of a salivary gland with anti-TAI
antibodies. TAI is expressed in the polyploid
nuclei. (B) Staining of a segment of a polytene
chromosome from a late third instar larval
salivary gland for USP. (C) DAPI staining of
the same chromosome segment. (D) Staining
of the same segment with anti-TAI antibodies
and a fluorescein conjugated secondary anti-
body. (E) Overlay image of DAPI and anti-
TAI staining. No colocalization is apparent.
(F) Overlay of TAI and USP. Overlap appears
as yellow. Scale bars 5 10 mm. (G) TAI-depen-
dent increases in hormone-regulated tran-
scription by the ecdysone receptor in culture
cells. EcR-293 cells were transiently trans-
fected with increasing amounts of pCDNA3-
tai, decreasing amounts of pCDNA (empty
vector), and reporter pIND/lacZ or placZ-
D5XE/GRE in the absence or presence of 2.5
mM of ponasterone A. b-galactosidase activ-
ity is expressed in relative light units (RLU).
Data shown represent the mean of three de-
terminations from one of four independent
experiments. Error bars indicate the stan-
dard errors of the means. (H) GST pulldown
assays for hormone-dependent interactions
between TAI, EcR, and USP. In vitro trans-
lated, [35S]methionine-labled EcRB1 alone (top
panel), [35S]methionine-labled USP alone (mid-
dle panel), or a mixture of [35S]methionine-
labled EcRB1 and [35S]methionine-labled USP
(bottom panel) were incubated with GST
(lanes 2 and 3), GST fused to the LXXLL do-
main of TAI (amino acids 1028–1035) (lanes
4 and 5), and GST fused to the N terminus of
TAI (amino acids 259–382) (lanes 6 and 7) in
the absence (minus sign: lanes 2, 4, and 6)
or presence (plus sign: lanes 3, 5, and 7) of
5 mM of ponasterone A. In lane 1, 50% of
input protein is shown.
one, with a substantial increase in transcriptional acti- (Freedman, 1999). TAI appears to be a coactivator of
this class based not only on amino acid sequence simi-vation of genes placed under the control of a cis-acting
sequence known as an E/GRE (see Experimental Proce- larity and overall domain structure, but based also on
its in vivo colocalization with EcR, its direct, ligand-dures for details). We compared transcriptional activa-
tion in cells expressing varying amounts of TAI in tran- dependent binding to EcR, and its ability to potentiate
sient transfection assays. As shown in Figure 7G, TAI hormone-dependent transcription in cultured cells.
expression increased transcriptional activation up to The homology of TAI to SRC proteins suggested that
5-fold, in a dose-dependent manner, specifically in the TAI might interact with a steroid hormone receptor. Al-
presence of hormone. though there are more than 20 genes in Drosophila that
Furthermore, a GST-fusion protein containing the re- code for proteins related to nuclear hormone receptors,
gion of TAI protein containing the LXXLL motifs pre- ecdysone is the only known steroid hormone. Since SRC
dicted to interact with EcR (residues 1028 to 1235 of proteins require the presence of a ligand in order to
TAI) associated with in vitro translated EcR in a ligand- interact with receptors, the ecdysone receptor seemed
dependent manner. The same fusion protein did not like the best candidate partner for TAI. The colocaliza-
associate detectably with USP alone (Figure 7). How- tion of TAI protein with the ecdysone receptor complex
ever, in the presence of EcR and ligand, the TAI-GST at specific chromosomal loci in third instar larva, the
fusion protein was able to coprecipitate USP (Figure 7). direct and ligand-dependent binding of TAI to EcR in
Taken together, these results suggest that TAI is a bona vitro, and the ability of TAI to potentiate the ecdysone
fide ecdysone receptor coactivator. response in cell culture lend substantial support to this
proposal.
Discussion The ligand-dependent interaction of TAI with the ec-
dysone receptor suggests that ecdysone regulates bor-
der cell migration. The strongest evidence in support ofThe tai Gene Encodes a Drosophila Steroid
Hormone Receptor Coactivator this is that border cells lacking USP were unable to
migrate. Consistent with this observation, Oro et al.The p160 class of steroid hormone receptor coactivators
has been thought to be missing from invertebrates (1992) reported that numerous unfertilized eggs were
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produced from females lacking usp function. Moreover known to promote progression of breast, ovarian, and
prostate cancers, which includes acquisition of highlyusp was required specifically in somatic cells for produc-
tion of a fertilizable egg (Oro et al., 1992). Although they invasive characteristics (Cuzick, 1996; Green and Furr,
1999). The prevailing view is that the hormones act todid not specifically examine border cell migration, de-
fects in border cell migration are known to lead to the stimulate proliferation of the cancer cells, leading to an
increased likelihood of mutation and appearance of anproduction of unfertilized eggs (Montell et al., 1992). We
have been unable to test whether EcR loss of function invasive phenotype. However, the data presented in this
paper suggest that steroid hormones can also stimulatemutations affect border cell migration. This is because
the EcR locus, at 42A, is proximal to available FRT inser- invasive behavior independently of any discernible ef-
fect on proliferation. Thus, steroid hormones, like manytions, making it impossible to make FLP-mediated mo-
saic clones. The frequency of X-ray induced mitotic peptide growth factors, may possess both mitogenic
and motogenic properties. This notion is supported byclones is too low to be useful, and marking such clones
is problematic. A temperature-sensitive allele of EcR studies that show effects of an anti-estrogen on metas-
tasis of prostate cancer cells in the rat. Raloxifene, anexists and flies at the nonpermissive temperature exhibit
a variety of defects in oogenesis, including arrest prior anti-estrogen, was found to inhibit metastasis of PAIII
adenocarcinoma cells to the lymph nodes and lungs, into border cell migration. Even though it was not possible
to assess the effect of EcR mutations specifically in the vivo, without effects on growth of the primary tumor, or
proliferation of the PAIII cells in vitro (Neubauer et al.,border cells, the observations that hormone injections
can lead to precocious border cell migration and that 1995). The treatment also extended the survival of the
animals.reduced ecdysone levels can lead to delayed migration
provide additional support for the hormonal control of
migration. The tai Gene and Its Interactions Define
The rise in ecdysone after eclosion, specifically in a slbo-Independent Pathway Required
females, occurs in response to adequate nutrition for Border Cell Migration
(Schwartz et al., 1985). In the absence of a rich diet, A number of genes that have been described, slbo, jing,
yolk protein synthesis is inhibited and oogenesis does breathless, cadherin, and PZ6356 define a slbo-depen-
not progress. Yolk protein synthesis can be restored in dent pathway required for border cell migration (re-
the absence of a rich diet by applying ecdysone or juve- viewed in Montell, 1999). Experiments reported here in-
nile hormone (JH) to cultured ovaries. Recent studies dicate that expression of DFAK also depends upon the
indicate that functional ecdysone receptors are required slbo pathway. In contrast, tai function appears to be
in the germline for progression of oogenesis through independent of slbo, based on the lack of effect of slbo
vitellogenesis, the stages during which yolk is taken up mutations on tai expression and the lack of effect of tai
by the oocyte (Buszczak et al., 1999; Carney and Bender, mutations on slbo expression. In addition, overexpres-
2000). In summary, then, adequate nutrition appears to sion of tai failed to rescue even mild slbo migration
lead to elevated hormone levels, which in turn stimulate defects and overexpression of slbo failed to rescue tai
yolk protein synthesis and uptake, and progression of migration defects (Bai and Montell, unpublished). Muta-
oogenesis beyond stage 8. Together with the results tions in either slbo or tai affect cadherin and DFAK.
reported here, these findings suggest that a rising ecdy- Whereas slbo function is required for expression of
sone titer coordinates a variety of events that occur in these two proteins, tai function is required for proper
early vitellogenic egg chambers, including border cell subcellular localization of both proteins.
migration.
Turnover of Adhesion Complexes in Cell Migration
The finding that DE-cadherin is required both in theSteroid Hormones in Cell Motility and Cancer
Our studies suggest a role for steroid hormones in cell border cells and in the nurse cells for normal border cell
migration was surprising since the prevailing view hasmotility that is independent of any role in cell prolifera-
tion or cell fate determination. If tai function were re- been that E-cadherin promotes formation of stable cell–
cell adhesion belts and inhibits motility (see for example,quired for follicle cell proliferation, it would not be possi-
ble to generate homozygous mutant clones since the Takeichi, 1993). However, there are numerous excep-
tions to the general correlation of decreased E-cadherinhomozygous mutant cells would fail to proliferate. We
found many homozygous mutant tai clones in the follicu- expression with increasing motility. One particularly in-
teresting exception is the human ovarian epitheliumlar epithelium, some of which were quite large; therefore,
there did not appear to be a requirement for tai function (Ong et al., 2000). Normal cells within the human ovar-
ian surface epithelium express relatively low levels ofin follicle cell proliferation. In addition, tai mutant border
cells clearly differentiated from the neighboring follicle E-cadherin. However, carcinomas derived from this epi-
thelium express high levels of E-cadherin, and overex-cells, based on their morphology, and they continued
to express all of the border cell markers we tested. pression of E-cadherin in T antigen transformed ovarian
surface epithelium cells causes them to become inva-Therefore, there did not appear to be any detectable
change of cell fate or differentiation state in these cells. sive and to form distant metastases in nude mice. Thus,
in both human and Drosophila ovaries, E-cadherinRather, they appear to have a relatively specific defect
in their ability to migrate through the neighboring nurse seems to promote rather than inhibit motility.
Why then do some cells respond to increased cad-cell cluster.
These findings may have significance for steroid hor- herin expression by increasing invasiveness whereas
other cells respond by decreasing invasiveness? Wemone-dependent human cancers since hormones are
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Hormone Treatment of Ovariespropose that the difference is that some cell types are
Flies containing a hs-slbo transgene were heat-shocked at 378C forcapable of rapidly turning over E-cadherin-containing
1 hr. After 5 hr at 258C, either 50 nl of 20-hydroxyecdysone (Sigma,adhesion complexes whereas other cells are not. If the
2 ng/nl in Ringer’s solution) or 50 nl of ponasterone A (10 ng/nl in
complexes can be turned over efficiently, the cells be- ethanol) was injected as described. Ringer’s alone or ethanol alone
have like wild-type border cells and become invasive. served as controls. Hs-slbo flies that had not been heat treated
were also injected. Migration was assayed 15 hr later in stage 8 eggIf the complexes cannot be turned over efficiently, the
chambers, when border cell migration is never observed in wildcells behave as tai mutant border cells, accumulate sta-
type. Premature border cell migration was observed in 5 out of 22ble cell–cell adhesion complexes and do not migrate.
egg chambers treated with heat shock and hormone, but not in
It will be important to identify the critical downstream controls. As expected, most egg chambers treated with hormone
targets of TAI because one or more of these may be a were also undergoing degeneration at stage 8.
protein important for turnover of adhesion complexes.
Steroid hormones may stimulate formation and turn- Molecular Identification of tai and Germline Transformation
The sequence flanking l(2)01351 was used in a BLAST search ofover of cadherin-containing cell adhesion complexes in
the entire Drosophila genome sequence and matched P1 clonehuman breast cancer as well. In support of this, DePas-
DS06958, a 108,924 base pair genomic sequence, which had beenquale has observed that MCF7 human breast cancer
completed by BDGP. Two ESTs, GH06208 and LP10313, were found
cells respond to b-estradiol treatment by extending mo- to correspond to portions of a coding sequence predicted by Gene-
tile lamellipodia, which make small, transient, E-cad- scan. Complete sequencing of these ESTs indicated that GH06208
and LP10313 spanned the translation start site and the predictedherin-containing contacts with underlying cells (DePas-
39 end of a transcript, respectively. To obtain a full-length cDNA ofquale, 1999). This behavior is prevented by treatment
taiman, RT-PCR was carried out using an RNA PCR Core kit (PERKINof the cells with anti-estrogens. Taken together with the
ELMER) and total RNA.
proven effectiveness of anti-estrogens in preventing and To construct a tai minigene, a BglII to EcoRI fragment of EST
reversing metastasis of hormone-dependent cancers, clone GH6208 was combined with an EcoRI fragment from P1 clone
these findings suggest that steroid hormones may stim- DS06958 and EST clone LP0313 in pUAST (Brand and Perrimon,
1993). For germline transformation, the pUAST-tai DNA was co-ulate invasive cell behavior by facilitating rapid turnover
injected into w1118 embryos with pp25.7WC helper plasmid accordingof E-cadherin containing cell adhesion complexes. This
to standard procedures. Several independent transformant linescould be one mechanism by which amplification of AIB1
were established.
contributes to the progression of breast and ovarian
cancer. Polyclonal Antibodies
Two fragments of the tai cDNA (amino acids 1028–1235 and 477–
687) were cloned into pGEX-5X-3 (Pharmacia) and used to produce
Experimental Procedures GST fusion proteins, which were used to immunize rabbits (antibody
JBL). Sera were diluted 1:2000 to carry out tissue immunostaining.
Drosophila Genetics No staining was observed in Df(2L)30A-C homozygous embryos.
The mosaic screen for mutations that caused border cell migration Preimmune sera failed to stain embryos, egg chambers, or third
defects was performed much as described for 2R (Liu and Montell, instar laval salivary glands.
1999) with the exception of the chromosomal location of FRT. One
allele of tai, tai61G1, was recovered from a screen of 2885 mutant
Immunohistochemistry and Immunofluorescence
lines. To map the tai locus, the original tai61G1 mutant was crossed Ovary dissections were performed in Grace’s medium plus 10% calf
to the deficiency kit for 2L (Bloomington Stock Center) and scored serum. For b-galactosidase staining, whole ovaries were fixed in
for lethality. Meiotic recombination mapping was performed by PBS containing 0.1% glutaraldehyde for 5 min, rinsed, and stained
crossing the original tai61G1 line to FRT40A. About 150 recombinants as described (Montell, 1999). Immunofluorescent localization of pro-
were scored for dp, PZ6356, and border cell migration defects in teins was carried out essentially as described. For double or triple
mosaic clones. All recombinants with border cell migration defects labeling, stained egg chambers were incubated with rhodamine-
failed to complement l(2)01351, a P element within Df(2L)30A-C. phalloidin (Molecular Probes) at 1:200 for 25 min followed by DAPI
Precise excision of this P element can reverse the lethal phenotype at a final concentration of 0.5 mg/ml and incubation for another 5 min.
of the original l(2)01351 line. Other P element alleles of the tai locus After three washes, egg chambers were mounted in VECTASHIELDt
l(2)k15101, l(2)k00810, l(2)k00813, l(2)k13426, l(2)k08502 were ob- (Vector Laboratories). Salivary glands from third instar larvae were
tained from Szeged while l(2)k05809, EP(2)2603, EP(2)1170 were dissected in PBS and fixed in PBS containing 3.7% formaldehyde
obtained from BDGP. l(2)01351, FRT40A/CyO was obtained from Nor- for 30 min. Staining was detected using the Elite ABC kit (Vector
bert Perrimon (Chou and Perrimon, 1996). Border cell migration Laboratories). Polytene chromosome staining was carried out as
defects were observed in l(2)01351 mosaic clones, and tai61G1/ described in Andrew and Scott (1994). Primary antibodies used
l(2)k05809 escapers exhibited border cell migration defects and were: mouse anti-Armadillo (N2 7A1, 1:200) (Developmental Studies
reduced fertility. Hybridoma Bank); rat anti-DE-cadherin (DCAD2, 1:20) (Uemura et
To negatively mark mosaic clones in the border cells, dp, tai61G1, al., 1996); rabbit anti-DFAK (1:1000) (Palmer et al., 1999); mouse
FRT40A/CyO flies were crossed to dp, PZ6356, FRT40A/dp, PZ6356, anti-EcR-A (15G1a, 1:50), mouse anti-EcR-B1 (AD4.4, 1:50) (Talbot
FRT40A. To positively mark clones in the border cells, the technique et al., 1993); mouse anti-USP (AB11, 1:50) (Christianson et al., 1992);
known as MARCM was employed as described (Lee and Luo, 1999). mouse anti-b-galatosidase (1:500) (Promega); and rabbit anti-b-
The alleles of slbo used were slboe7b, slbo1310, slbory8 (Montell et al., galatosidase (1:2000) (Cappel). The secondary antibodies used were:
1992). horse fluorescein anti-mouse (Vector Laboratories); CyTM5-conju-
The ecd1 allele of ecdysoneless was obtained from the Blooming- gated donkey anti-rabbit; fluorescein (FITC) conjugated donkey anti-
rabbit; fluorescein (FITC) conjugated donkey anti-rat; rhodamineton Stock Center. After 2 days or 5 days at 298C, ovaries were
redTM-X-conjugated donkey anti-mouse; rhodamine redTM-X-conju-dissected and stained with anti-SLBO antibodies (Montell et al.,
gated donkey anti-rabbit (Jackson ImmunoResearch).1992). No staining was observed in 5-day ovaries, which combined
egg chambers were arrested at stage 8, and degenerating. 2-day
ovaries contained stage 10 egg chambers, 50% of which (30/59) Cell Culture and Transient Transfections
exhibited delayed border cell migration. No egg chamber from wild- EcR-293 cells (Invitrogen) were maintained in complete medium
type females kept at 298C or from ecd1 females kept at 208C exhibited containing DEME (GibcoBRL), 10% fetal bovine serum (Gibco BRL)
and 400 mg/ml ZeocinTM (Invitrogen). Transient transfections weredelayed border cell migration.
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performed using the Calcium Phosphate Transfection method (Chen factor chorion factor 1/ultraspiracle. Proc. Natl. Acad. Sci. USA 89,
11503–11507.and Okayama, 1987). Transfected cells were re-fed with fresh me-
dium containing either vehicle (ethanol) alone or vehicle plus 2.5 mM Cuzick, J. (1996). Medicinal drugs with hormonal activity as chemo-
Ponasterone A (Invitrogen) and were harvested 20 hr after treatment. preventive agents. IARC Sci. Publ. 139, 99–114.
Transfections using b-galactosidase as the reporter were assayed
DePasquale, J.A. (1999). Rearrangement of the F-actin cytoskeletonusing the Galacto-Light PlusTM kit (Tropix). Transfections using lucif-
in estradiol-treated MCF-7 breast carcinoma cells. Histochem. Cellerase as the reporter were assayed with the Enhanced Luciferase
Biol. 112, 341–350.Assay Kit (PHARMINGEN).
Fox, G.L., Rebay, I., and Hynes, R.O. (1999). Expression of DFak56,
a Drosophila homolog of vertebrate focal adhesion kinase, supportsGST Pulldown Assays
a role in cell migration in vivo. Proc. Natl. Acad. Sci. USA 96, 14978–35S-methionine-labeled EcR and USP were generated in a coupled
14983.transcription–translation system, TNT (Promega), using CMX-EcR
(T7) and CMX-uspK (T7) constructs (Tsai et al., 1999), respectively, Freedman, L.P. (1999). Increasing the complexity of coactivation in
as templates. Glutathione S-transferase (GST) fusion proteins, GST- nuclear receptor signaling. Cell 97, 5–8.
LXXLLs (amino acids 1028–1235) and GST-N (amino acids 259–382), Fujimoto, J., Sawamoto, K., Okabe, M., Takagi, Y., Tezuka, T., Yoshi-
were expressed in BL21 cells. In vitro GST-pulldown assays were kawa, S., Ryo, H., Okano, H., and Yamamoto, T. (1999). Cloning and
performed as described in Tsai et al. (1999). Where indicated, 5 mM characterization of Dfak56, a homolog of focal adhesion kinase, in
Ponasterone A was added. Drosophila melanogaster. J. Biol. Chem. 274, 29196–29201.
Green, S., and Furr, B. (1999). Prospects for the treatment of endo-Supplemental Experimental Procedures
crine-responsive tumours. Endocr. Relat. Cancer 6, 349–371.The Experimental Procedures given here have been abridged due
Guilford, P. (1999). E-cadherin downregulation in cancer: fuel on theto space constraints. A full-length version of the Experimental Pro-
fire? Mol. Med. Today 5, 172–177.cedures is available online (http://www.cell.com/cgi/content/full/
103/7/1047/DC1). Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji,
N., Nomura, S., Fujimoto, J., Okada, M., and Yamamoto, T. (1995).
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